Invest in Gerostate Alpha (YC S18)

A pharmaceutical company dedicated to treating aging and age-related disease

gerostatealpha.com

San Francisco CA

Technology Life Science Bio Tech Moonshots Healthcare

Highlights

💵 $2.1M raised in initial seed round, at $15M valuation

🧬 Team at the forefront of aging research for decades, collectively authoring 200+ papers

💪 Our platform delivers drug candidates to slow aging at a success rate of 20%

🐭 Funds will be used to test 10-15 of our hits in aging mice

🧳 Executive chairman was former CEO of major pharma company, Sangamo Therapeutics

Our Team

CEO

PhD; Professor at Buck Institute for Research on Aging & CEO of Gerostate Alpha

We know how to stop the threat of chronic disease; and we care because aging is 100% fatal

CTO

PhD; Expert in small molecule and genetic screens including significant experience with high throughput technologies, and has utilized simple model organisms to explore pharmacological extension of lifespan.

Gordon Lithgow Professor, Vice President Buck Institute

PhD; Chief Academic Officer at the Buck Institute for Research on Aging and specializes in the properties of small molecules to extend lifespan, having been internationally recognized for his work on aging with numerous awards and prizes.